PD1 blockade enhances K<sup>+</sup> channel activity, Ca<sup>2+</sup> signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancerHannah S. Newton, Laura Conforti, Vaibhavkumar S. Gawali et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 33
Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Shuchi Gulati et al.|Clinical Cancer Research|2022Cited by 26
Gene expression signature after one dose of neoadjuvant pembrolizumab associated with tumor response in head and neck squamous cell carcinoma (HNSCC).Eejung Kim, Trisha M. Wise‐Draper, Sarah Palackdharry et al.|Journal of Clinical Oncology|2018Cited by 4
KCa3.1 channels regulate the tumor infiltration of functionally competent NK cells in head and neck cancerAbdulaziz O. Alshwimi, Laura Conforti, Ameet A. Chimote et al.|Scientific Reports|2025Cited by 1
Data from Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and NeckJennifer L. Leddon, Trisha M. Wise‐Draper, Shuchi Gulati et al.|Unknown|2023Cited by 1